Karagas MR - Search Results

1

Review of processing and analysis methods for DNA methylation array data.

Wilhelm-Benartzi CS, Koestler DC, Karagas MR, Flanagan JM, Christensen BC, Kelsey KT, Marsit CJ, Houseman EA, Brown R. Wilhelm-Benartzi CS, et al. Among authors: karagas mr. Br J Cancer. 2013 Sep 17;109(6):1394-402. doi: 10.1038/bjc.2013.496. Epub 2013 Aug 27. Br J Cancer. 2013. PMID: 23982603 Free PMC article. Review.

2

Fas/APO-1 promoter polymorphism is not associated with non-melanoma skin cancer.

Nelson HH, Kelsey KT, Bronson MH, Mott LA, Karagas MR. Nelson HH, et al. Among authors: karagas mr. Cancer Epidemiol Biomarkers Prev. 2001 Jul;10(7):809-10. Cancer Epidemiol Biomarkers Prev. 2001. PMID: 11440968 No abstract available.

3

The XRCC1 Arg399Gln polymorphism, sunburn, and non-melanoma skin cancer: evidence of gene-environment interaction.

Nelson HH, Kelsey KT, Mott LA, Karagas MR. Nelson HH, et al. Among authors: karagas mr. Cancer Res. 2002 Jan 1;62(1):152-5. Cancer Res. 2002. PMID: 11782372

4

A population-based study of immunohistochemical detection of p53 alteration in bladder cancer.

Kelsey KT, Hirao T, Schned A, Hirao S, Devi-Ashok T, Nelson HH, Andrew A, Karagas MR. Kelsey KT, et al. Among authors: karagas mr. Br J Cancer. 2004 Apr 19;90(8):1572-6. doi: 10.1038/sj.bjc.6601748. Br J Cancer. 2004. PMID: 15083187 Free PMC article.

5

A population-based case-control study of the XRCC1 Arg399Gln polymorphism and susceptibility to bladder cancer.

Kelsey KT, Park S, Nelson HH, Karagas MR. Kelsey KT, et al. Among authors: karagas mr. Cancer Epidemiol Biomarkers Prev. 2004 Aug;13(8):1337-41. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 15298955

6

Gender, smoking, glutathione-S-transferase variants and bladder cancer incidence: a population-based study.

Karagas MR, Park S, Warren A, Hamilton J, Nelson HH, Mott LA, Kelsey KT. Karagas MR, et al. Cancer Lett. 2005 Feb 28;219(1):63-9. doi: 10.1016/j.canlet.2004.10.006. Cancer Lett. 2005. PMID: 15694665

7

The XPC poly-AT polymorphism in non-melanoma skin cancer.

Nelson HH, Christensen B, Karagas MR. Nelson HH, et al. Among authors: karagas mr. Cancer Lett. 2005 May 26;222(2):205-9. doi: 10.1016/j.canlet.2004.11.032. Epub 2005 Jan 7. Cancer Lett. 2005. PMID: 15863269

8

TP53 alterations and patterns of carcinogen exposure in a U.S. population-based study of bladder cancer.

Kelsey KT, Hirao T, Hirao S, Devi-Ashok T, Nelson HH, Andrew A, Colt J, Baris D, Morris JS, Schned A, Karagas M. Kelsey KT, et al. Int J Cancer. 2005 Nov 10;117(3):370-5. doi: 10.1002/ijc.21195. Int J Cancer. 2005. PMID: 15906354

9

Carcinogen exposure and gene promoter hypermethylation in bladder cancer.

Marsit CJ, Karagas MR, Danaee H, Liu M, Andrew A, Schned A, Nelson HH, Kelsey KT. Marsit CJ, et al. Among authors: karagas mr. Carcinogenesis. 2006 Jan;27(1):112-6. doi: 10.1093/carcin/bgi172. Epub 2005 Jun 29. Carcinogenesis. 2006. PMID: 15987713

10

Epigenetic inactivation of SFRP genes and TP53 alteration act jointly as markers of invasive bladder cancer.

Marsit CJ, Karagas MR, Andrew A, Liu M, Danaee H, Schned AR, Nelson HH, Kelsey KT. Marsit CJ, et al. Among authors: karagas mr. Cancer Res. 2005 Aug 15;65(16):7081-5. doi: 10.1158/0008-5472.CAN-05-0267. Cancer Res. 2005. PMID: 16103055

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

558 results

Search Page